{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T21:14:09Z","timestamp":1789074849152,"version":"build-2803163510"},"reference-count":56,"publisher":"The Royal Society","issue":"1944","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Government Department of Health and Social Care"},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In April 2024, the Royal Society convened a Science+ meeting in London on \u2018Vaccines and antimicrobial resistance: from science to policy\u2019. The purpose was to review the science of how vaccines reduce antimicrobial resistance (AMR) and discuss policy in advancing development and equitable deployment of such vaccines. The meeting adopted a One Health approach with international speakers presenting from both human and veterinary perspectives. Presentations on Day 1 focused on scientific aspects of the AMR threat and the role of vaccines as counter measures. On Day 2, presentations covered associated policy implications based on this scientific understanding. A closing panel discussion looked towards the United Nations High-Level Meeting on AMR in New York in September 2024. This article is the closing contribution to an issue of Philosophical Transactions of the Royal Society B based on the meeting. It serves as a summary of the two days of proceedings, including key outcomes and recommendations, and provides an overall conclusion to the meeting.<\/jats:p>\n                  <jats:p>This article is part of the Royal Society Science+ meeting issue \u2018Vaccines and antimicrobial resistance: from science to policy\u2019.<\/jats:p>","DOI":"10.1098\/rstb.2025.0012","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T08:28:10Z","timestamp":1771489690000},"source":"Crossref","is-referenced-by-count":1,"title":["Vaccines and antimicrobial resistance: from science to policy\u2014summary and outcomes"],"prefix":"10.1098","volume":"381","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9694-0846","authenticated-orcid":false,"given":"Calman A.","family":"MacLennan","sequence":"first","affiliation":[{"name":"University of Birmingham 1 , ,","place":["Birmingham, UK"],"department":["Department of Immunology and Immunotherapy, College of Medical and Dental Sciences"]},{"name":"University of Oxford 2 , ,","place":["Oxford, UK"],"department":["Jenner Institute, Nuffield Department of Medicine, Medical Sciences Division"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Hasso-Agopsowicz","sequence":"additional","affiliation":[{"name":"World Health Organization 3 , ,","place":["Geneva, Switzerland"],"department":["Department of Immunization, Vaccines and Biologicals"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin M.","family":"Abuga","sequence":"additional","affiliation":[{"name":"KEMRI-Wellcome Trust Research Programme 4 , ,","place":["Kilifi, Kenya"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Adegbola","sequence":"additional","affiliation":[{"name":"Nigerian Institute of Medical Research 5 , ,","place":["Lagos, Nigeria"],"department":["Department of Microbiology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6413-1718","authenticated-orcid":false,"given":"Annaliesa S.","family":"Anderson","sequence":"additional","affiliation":[{"name":"Pfizer Inc 6 , , ,","place":["Pearl River, NY, USA"],"department":["Vaccines R&D"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Borriello","sequence":"additional","affiliation":[{"name":"Food Standards Agency 7 , ,","place":["London, UK"],"department":["Science Advisory Committee"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ed","family":"Buurman","sequence":"additional","affiliation":[{"name":"Boston University 8 , , ,","place":["Boston, MA, USA"],"department":["CARB-X"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan E.","family":"Carey","sequence":"additional","affiliation":[{"name":"London School of Hygiene and Tropical Medicine 9 , ,","place":["London, UK"],"department":["Department of Infection Biology"]},{"name":"MMGH Consulting 10 , ,","place":["Zurich, Switzerland"]},{"name":"Amsterdam Institute for Global Health and Development 11 , ,","place":["Amsterdam, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mwelwa","family":"Chibuye","sequence":"additional","affiliation":[{"name":"Amsterdam Institute for Global Health and Development 11 , ,","place":["Amsterdam, The Netherlands"]},{"name":"Center for Infectious Disease Research in Zambia 12 , ,","place":["Lusaka, Zambia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duncan J.","family":"Colquhoun","sequence":"additional","affiliation":[{"name":"Norwegian Veterinary Institute 13 , ,","place":["\u00c5s, Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rory","family":"Cooney","sequence":"additional","affiliation":[{"name":"Veterinary Medicines Directorate 14 , ,","place":["Addlestone, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2036-5467","authenticated-orcid":false,"given":"Fr\u00e9d\u00e9ric","family":"Descamps","sequence":"additional","affiliation":[{"name":"Zoetis Belgium SA 15 , ,","place":["Zaventem, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Dougan","sequence":"additional","affiliation":[{"name":"University of Cambridge 16 , ,","place":["Cambridge, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Kaslow","sequence":"additional","affiliation":[{"name":"US Food and Drug Administration 17 , , ,","place":["Silver Spring, MD, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry W.","family":"Komo","sequence":"additional","affiliation":[{"name":"KEMRI-Centre for Global Health Research 18 , ,","place":["Kisumu, Kenya"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9103-0402","authenticated-orcid":false,"given":"Richard","family":"Hatchett","sequence":"additional","affiliation":[{"name":"Coalition for Epidemic Preparedness Innovations 19 , ,","place":["Oslo, Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6650-3960","authenticated-orcid":false,"given":"William P.","family":"Hausdorff","sequence":"additional","affiliation":[{"name":"PATH 20 , , ,","place":["Washington, DC, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"La Ragione","sequence":"additional","affiliation":[{"name":"University of Surrey 21 , ,","place":["Guildford, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9e","family":"Larocque","sequence":"additional","affiliation":[{"name":"International Development Research Centre 22 , , ,","place":["Ottawa, Ontario, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramanan","family":"Laxminarayan","sequence":"additional","affiliation":[{"name":"One Health Trust 23 , , ,","place":["Washington, DC, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"McDonnell","sequence":"additional","affiliation":[{"name":"Center for Global Development 24 , ,","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"O'Brien","sequence":"additional","affiliation":[{"name":"World Health Organization 3 , ,","place":["Geneva, Switzerland"],"department":["Department of Immunization, Vaccines and Biologicals"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.A.","family":"Oliveira","sequence":"additional","affiliation":[{"name":"Instituto Oswaldo Cruz, FIOCRUZ 25 , ,","place":["Rio de Janeiro, Brazil"],"department":["Laborat\u00f3rio de Enterobact\u00e9rias"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah N.","family":"Qamar","sequence":"additional","affiliation":[{"name":"Aga Khan University 26 , ,","place":["Karachi, Pakistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rino","family":"Rappuoli","sequence":"additional","affiliation":[{"name":"Fondazione Biotecnopolo di Siena 27 , ,","place":["Siena, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Tufet","sequence":"additional","affiliation":[{"name":"GAVI the Vaccine Alliance 28 , ,","place":["Geneva, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Westwood","sequence":"additional","affiliation":[{"name":"International Center for Antimicrobial Resistance Solutions (ICARS) 29 , ,","place":["Copenhagen, Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0808-102X","authenticated-orcid":false,"given":"Javier","family":"Yugueros-Marcos","sequence":"additional","affiliation":[{"name":"World Organisation for Animal Health 30 , ,","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally C.","family":"Davies","sequence":"additional","affiliation":[{"name":"University of Cambridge 31 , ,","place":["Cambridge, UK"],"department":["Trinity College"]},{"name":"United Kingdom Department of Health and Social Care 32 , ,","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"175","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"key":"2026021903280888300_R1","unstructured":"The Royal Society\n          . 2024Vaccines and antimicrobial resistance: from science to policy. Seehttps:\/\/royalsociety.org\/science-events-and-lectures\/2024\/04\/vaccines-amr\/#:~:text=Reducing%20the%20need%20for%20antibiotics,lowering%20the%20burden%20of%20AMR."},{"key":"2026021903280888300_R2","doi-asserted-by":"crossref","first-page":"20250001","DOI":"10.1098\/rstb.2025.0001","article-title":"Vaccines and antimicrobial resistance: from science to policy\u2014introduction","volume":"381","author":"MacLennan","year":"2026","journal-title":"Phil. Trans. R. Soc. B"},{"key":"2026021903280888300_R3","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127210","article-title":"BactiVac, the bacterial vaccines network","volume":"57","author":"MacLennan","year":"2025","journal-title":"Vaccine"},{"key":"2026021903280888300_R4","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/S0140-6736(22)02185-7","article-title":"Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease study 2019","volume":"400","author":"GBD 2019 Antimicrobial Resistance Collaborators","year":"2022","journal-title":"Lancet"},{"key":"2026021903280888300_R5","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Antimicrobial Resistance Collaborators.","year":"2022","journal-title":"Lancet"},{"key":"2026021903280888300_R6","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1016\/S0140-6736(24)01019-5","article-title":"Ensuring progress on sustainable access to effective antibiotics at the 2024 UN General Assembly: a target-based approach","volume":"403","author":"Mendelson","year":"2024","journal-title":"Lancet"},{"key":"2026021903280888300_R7","doi-asserted-by":"crossref","first-page":"e909","DOI":"10.1016\/S2214-109X(20)30205-9","article-title":"Initial findings from a novel population-based child mortality surveillance approach: a descriptive study","volume":"8","author":"Taylor","year":"2020","journal-title":"Lancet Glob. Health"},{"key":"2026021903280888300_R8","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41564-021-00870-7","article-title":"Characterization of antimicrobial-resistant Gram-negative bacteria that cause neonatal sepsis in seven low- and middle-income countries","volume":"6","author":"Sands","year":"2021","journal-title":"Nat. Microbiol."},{"key":"2026021903280888300_R9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004179","article-title":"Patterns of antibiotic use, pathogens, and prediction of mortality in hospitalized neonates and young infants with sepsis: a global neonatal sepsis observational cohort study (NeoOBS)","volume":"20","author":"Russell","year":"2023","journal-title":"PLoS Med."},{"key":"2026021903280888300_R10","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1016\/S0140-6736(24)00876-6","article-title":"The scope of the antimicrobial resistance challenge","volume":"403","author":"Okeke","year":"2024","journal-title":"Lancet"},{"key":"2026021903280888300_R11","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1016\/S0140-6736(24)00862-6","article-title":"Burden of bacterial antimicrobial resistance in low-income and middle-income countries avertible by existing interventions: an evidence review and modelling analysis","volume":"403","author":"Lewnard","year":"2024","journal-title":"Lancet"},{"key":"2026021903280888300_R12","doi-asserted-by":"crossref","first-page":"20250002","DOI":"10.1098\/rstb.2025.0002","article-title":"Economic impact of a maternal Klebsiella pneumoniae vaccine: estimates for 107 low- and middle-income countries","volume":"381","author":"Impalli","year":"2026","journal-title":"Phil. Trans. R. Soc. B"},{"key":"2026021903280888300_R13","unstructured":"World Bank Group\n          . 2017Drug-resistant infections: a threat to our economic future. Seehttps:\/\/documents1.worldbank.org\/curated\/en\/323311493396993758\/pdf\/final-report.pdf."},{"key":"2026021903280888300_R14","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2024-016249","article-title":"The global economic burden of antibiotic-resistant infections and the potential impact of bacterial vaccines: a modelling study","volume":"10","author":"Naylor","year":"2025","journal-title":"BMJ Glob. Health"},{"key":"2026021903280888300_R15","volume-title":"Forecasting the fallout from AMR: economic impacts of antimicrobial resistance in humans\u2014a report from the EcoAMR series","author":"McDonnell","year":"2024"},{"key":"2026021903280888300_R16","unstructured":"World Health Organization\n          . 2021Leveraging vaccines to reduce antibiotic use and prevent antimicrobial resistance: an action framework and annexe to Immunization Agenda 2030. Seehttps:\/\/www.who.int\/publications\/m\/item\/leveraging-vaccines-to-reduce-antibiotic-use-and-prevent-antimicrobial-resistance."},{"key":"2026021903280888300_R17","unstructured":"World Health Organization\n          . 2024Estimating the impact of vaccines in reducing antimicrobial resistance and antibiotic use: a technical report. Seehttps:\/\/iris.who.int\/server\/api\/core\/bitstreams\/b3bfc77f-c8fb-4076-a0e8-3b50780925ee\/content."},{"key":"2026021903280888300_R18","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(21)00311-6","article-title":"Zimbabwe tackles typhoid and cholera through vaccination","volume":"2","author":"Bagcchi","year":"2021","journal-title":"Lancet Microbe"},{"key":"2026021903280888300_R19","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2112410119","article-title":"Prevention of antimicrobial prescribing among infants following maternal vaccination against respiratory syncytial virus","volume":"119","author":"Lewnard","year":"2022","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2026021903280888300_R20","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1086\/605087","article-title":"The effect of universal influenza immunization on antibiotic prescriptions: an ecological study","volume":"49","author":"Kwong","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"2026021903280888300_R21","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41586-020-2238-4","article-title":"Childhood vaccines and antibiotic use in low- and middle-income countries","volume":"581","author":"Lewnard","year":"2020","journal-title":"Nature"},{"key":"2026021903280888300_R22","doi-asserted-by":"crossref","DOI":"10.1186\/s12992-022-00878-6","article-title":"Assessment of the inclusion of vaccination as an intervention to reduce antimicrobial resistance in AMR national action plans: a global review","volume":"18","author":"van Heuvel","year":"2022","journal-title":"Glob. Health"},{"key":"2026021903280888300_R23","doi-asserted-by":"crossref","first-page":"20250007","DOI":"10.1098\/rstb.2025.0007","article-title":"Vaccines against antimicrobial resistance","volume":"381","author":"Anderson","year":"2026","journal-title":"Phil. Trans. R. Soc. B"},{"key":"2026021903280888300_R24","doi-asserted-by":"crossref","first-page":"20250004","DOI":"10.1098\/rstb.2025.0004","article-title":"Technologies to support vaccine development against antimicrobial-resistant bacteria","volume":"381","author":"Cardinali","year":"2026","journal-title":"Phil. Trans. R. Soc. B"},{"key":"2026021903280888300_R25","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1126\/science.287.5459.1816","article-title":"Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing","volume":"287","author":"Pizza","year":"2000","journal-title":"Science"},{"key":"2026021903280888300_R26","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0140-6736(17)31449-6","article-title":"Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study","volume":"390","author":"Petousis-Harris","year":"2017","journal-title":"Lancet"},{"key":"2026021903280888300_R27","doi-asserted-by":"crossref","first-page":"e1154","DOI":"10.1016\/S2214-109X(21)00255-2","article-title":"Effectiveness of typhoid conjugate vaccine against culture-confirmed Salmonella enterica serotype Typhi in an extensively drug-resistant outbreak setting of Hyderabad, Pakistan: a cohort study","volume":"9","author":"Yousafzai","year":"2021","journal-title":"Lancet Glob. Health"},{"key":"2026021903280888300_R28","first-page":"20250005","article-title":"Role of pneumococcal and typhoid conjugate vaccines in mitigating antimicrobial resistance: report of conference proceeding","volume":"381","author":"Qamar","year":"2026","journal-title":"Phil. Trans. R. Soc. B"},{"key":"2026021903280888300_R29","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1056\/NEJMoa1401914","article-title":"Effects of vaccination on invasive pneumococcal disease in South Africa","volume":"371","author":"von Gottberg","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"2026021903280888300_R30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001107","article-title":"Effects of community-wide vaccination with PCV-7 on pneumococcal nasopharyngeal carriage in the Gambia: a cluster-randomized trial","volume":"8","author":"Roca","year":"2011","journal-title":"PLoS Med."},{"key":"2026021903280888300_R31","unstructured":"HealthforAnimals\n          . 2023Animal health and antibiotic resistance: a livestock data analysis. Seehttps:\/\/healthforanimals.org\/wp-content\/uploads\/2023\/11\/Animal-Health-and-Antimicrobial-Resistance-A-Livestock-Data-Analysis.pdf."},{"key":"2026021903280888300_R32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4939-3389-1_1","article-title":"Challenges in veterinary vaccine development and immunization","volume":"1404","author":"Chambers","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"2026021903280888300_R33","unstructured":"Fiskeridirektoratet\n          . 2025Akvakulturstatistikk: laks, regnbue\u00f8rret og \u00f8rret (offisiell statistikk). Seehttps:\/\/www.fiskeridir.no\/statistikk-tall-og-analyse\/data-og-statistikk-om-akvakultur\/akvakulturstatistikk-laks-regnbueorret-og-orret-offisiell-statistikk#1."},{"key":"2026021903280888300_R34","unstructured":"Veterin\u00e6rinstituttet\n          . 2023NORM\/NORM-VET 2022. Usage of antimicrobial agents and occurrence of antimicrobial resistance in Norway. Seehttps:\/\/www.vetinst.no\/overvaking\/antibiotikaresistens-norm-vet\/_\/attachment\/inline\/de166a6d-f9f2-4a4e-bd14-de53e97129de:4d3edbec655e1a37c79f12f8f16105cfaf255f7d\/NORM%20NORM-VET%202022.pdf."},{"key":"2026021903280888300_R35","unstructured":"Veterin\u00e6rinstituttet\n          . 2024Norwegian Fish Health Report 2023. Seehttps:\/\/www.vetinst.no\/rapporter-og-publikasjoner\/rapporter\/2024\/fishhealthreport-2023."},{"key":"2026021903280888300_R36","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10040554","article-title":"The inverse relationship between influenza vaccination and antimicrobial resistance: an ecological analysis of Italian data","volume":"10","author":"Barchitta","year":"2022","journal-title":"Vaccines"},{"key":"2026021903280888300_R37","doi-asserted-by":"crossref","first-page":"7138","DOI":"10.1016\/j.vaccine.2020.08.068","article-title":"Ten year public health impact of 13-valent pneumococcal conjugate vaccination in infants: a modelling analysis","volume":"38","author":"Chapman","year":"2020","journal-title":"Vaccine"},{"key":"2026021903280888300_R38","unstructured":"European Medicines Agency\n          . 2022European Surveillance of Veterinary Antimicrobial Consumption, 2022. Sales of veterinary antimicrobial agents in 31 European countries in 2021. Seehttps:\/\/www.ema.europa.eu\/en\/documents\/report\/sales-veterinary-antimicrobial-agents-31-european-countries-2021-trends-2010-2021-twelfth-esvac-report_en.pdf."},{"key":"2026021903280888300_R39","article-title":"Vaccines as alternatives to antibiotics for food producing animals. Part 1: challenges and needs","volume":"49","author":"Hoelzer","year":"2018","journal-title":"Vet. Res."},{"key":"2026021903280888300_R40","first-page":"20250103","article-title":"Vaccines and antimicrobial resistance\u2014a veterinary pharmaceutical industry perspective","volume":"381","author":"Descamps","year":"2026","journal-title":"Phil. Trans. R. Soc. B"},{"key":"2026021903280888300_R41","doi-asserted-by":"crossref","first-page":"20250008","DOI":"10.1098\/rstb.2025.0008","article-title":"Lessons from COVID: the 100 days mission and AMR","volume":"381","author":"Hatchett","year":"2026","journal-title":"Phil. Trans. R. Soc. B"},{"key":"2026021903280888300_R42","article-title":"Vaccines as alternatives to antibiotics for food producing animals. Part 2: new approaches and potential solutions","volume":"49","author":"Hoelzer","year":"2018","journal-title":"Vet. Res."},{"key":"2026021903280888300_R43","unstructured":"World Organisation for Animal Health\n          . ANIMUSE, the global database on ANImal antiMicrobial USE. Seehttps:\/\/amu.woah.org\/amu-system-portal\/home."},{"key":"2026021903280888300_R44","doi-asserted-by":"crossref","first-page":"201","DOI":"10.20506\/rst.42.3363","article-title":"Antimicrobial use in animals: a journey towards integrated surveillance","volume":"42","author":"Jeannin","year":"2023","journal-title":"Rev. Sci. Tech."},{"key":"2026021903280888300_R45","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1601410","article-title":"Livestock vaccinations translate into increased human capital and school attendance by girls","volume":"2","author":"Marsh","year":"2016","journal-title":"Sci. Adv."},{"key":"2026021903280888300_R46","first-page":"867","article-title":"Human health benefits from livestock vaccination for brucellosis: case study","volume":"81","author":"Roth","year":"2003","journal-title":"Bull. World Health Organ."},{"key":"2026021903280888300_R47","unstructured":"World Organisation for Animal Health\n          . 2024Accelerating action against antimicrobial resistance: closing the gaps in the animal health sector.Seehttps:\/\/www.woah.org\/en\/document\/accelerating-action-against-antimicrobial-resistance-closing-the-gaps-in-the-animal-health-sector\/."},{"key":"2026021903280888300_R48","doi-asserted-by":"crossref","first-page":"20250009","DOI":"10.1098\/rstb.2025.0009","article-title":"Animal vaccines and antimicrobial resistance: an underutilized tool","volume":"381","author":"Yugueros-Marcos","year":"2026","journal-title":"Phil. Trans. R. Soc. B"},{"key":"2026021903280888300_R49","unstructured":"Gavi\n          . Gavi the vaccine alliance. Seehttps:\/\/www.gavi.org\/."},{"key":"2026021903280888300_R50","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2025.0010","article-title":"Leveraging vaccine policy and investments for the AMR challenge","volume":"381","author":"Jadeja","year":"2026","journal-title":"Phil. Trans. R. Soc. B"},{"key":"2026021903280888300_R51","unstructured":"CARB-X\n          . CARB-X combating antiobiotic-resistant bacteria. Seehttps:\/\/carb-x.org\/."},{"key":"2026021903280888300_R52","doi-asserted-by":"crossref","first-page":"100368","DOI":"10.1016\/j.jvacx.2023.100368","article-title":"Exploring Shigella vaccine priorities and preferences: results from a mixed-methods study in low- and middle-income settings","volume":"15","author":"Fleming","year":"2023","journal-title":"Vaccine X"},{"key":"2026021903280888300_R53","doi-asserted-by":"crossref","first-page":"20250011","DOI":"10.1098\/rstb.2025.0011","article-title":"Anti-microbial resistance vaccines: communicating their true value","volume":"381","author":"Hausdorff","year":"2026","journal-title":"Phil. Trans. R. Soc. B"},{"key":"2026021903280888300_R54","unstructured":"ReAcT. Antibiotic resistance - a complex global challenge. Seehttps:\/\/www.reactgroup.org\/antibiotic-resistance\/a-complex-global-challenge\/."},{"key":"2026021903280888300_R55","unstructured":"United Nations\n          . 2024UN High-level Meeting on Antimicrobial Resistance. Seehttps:\/\/www.un.org\/en\/civil-society\/high-level-meeting-antimicrobial-resistance."},{"key":"2026021903280888300_R56","unstructured":"United Nations\n          . 2024Political Declaration of the High-level Meeting on Antimicrobial Resistance. Seehttps:\/\/www.un.org\/pga\/wp-content\/uploads\/sites\/108\/2024\/09\/FINALText-AMR-to-PGA.pdf."}],"container-title":["Philosophical Transactions B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/royalsocietypublishing.org\/rstb\/article-pdf\/doi\/10.1098\/rstb.2025.0012\/6112748\/rstb.2025.0012.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/royalsocietypublishing.org\/rstb\/article-pdf\/doi\/10.1098\/rstb.2025.0012\/6112748\/rstb.2025.0012.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T08:28:18Z","timestamp":1771489698000},"score":1,"resource":{"primary":{"URL":"https:\/\/royalsocietypublishing.org\/rstb\/article\/381\/1944\/20250012\/480438\/Vaccines-and-antimicrobial-resistance-from-science"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":56,"journal-issue":{"issue":"1944","published-online":{"date-parts":[[2026,2,19]]},"published-print":{"date-parts":[[2026,2,19]]}},"URL":"https:\/\/doi.org\/10.1098\/rstb.2025.0012","relation":{},"ISSN":["0962-8436","1471-2970"],"issn-type":[{"value":"0962-8436","type":"print"},{"value":"1471-2970","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"article-number":"20250012"}}